Literature DB >> 6157333

Close relationship of Crimean hemorrhagic fever-Congo (CHF-C) virus strains by neutralizing antibody assays.

G H Tignor, A L Smith, J Casals, C D Ezeokoli, J Okoli.   

Abstract

Strains of Crimean hemorrhagic fever-Congo (CHF-C) virus originating in widely separated points representing diverse zoogeograhiczl and ecological areas were compared by a neutralization of fluorescent foci of infection-test, in an attempt to determine whether antigenic differences could be detected among the strains. Minor differences were found which could be confirmed by reciprocal kinetic neutralization tests with one-injection immune sera if the results were analyzed by linear regression. However, CHF-C virus strains cannot be reliably subdivided into geographic variants on the basis of the minor antigenic variations observed. In this apparent paucity of antigenic diversity over its wide distribution, CHF-C virus differs from other arboviruses with similar or even lesser distribution.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6157333     DOI: 10.4269/ajtmh.1980.29.676

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  4 in total

1.  Enzyme-linked immunosorbent assays for the detection of antibody to Crimean-Congo haemorrhagic fever virus in the sera of livestock and wild vertebrates.

Authors:  F J Burt; R Swanepoel; L E Braack
Journal:  Epidemiol Infect       Date:  1993-12       Impact factor: 2.451

2.  Evidence from the anti-idiotypic network that the acetylcholine receptor is a rabies virus receptor.

Authors:  C A Hanham; F Zhao; G H Tignor
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

3.  Pseudo-plaque reduction neutralization test (PPRNT) for the measurement of neutralizing antibodies to Crimean-Congo hemorrhagic fever virus.

Authors:  Nurettin Canakoglu; Engin Berber; Mustafa Ertek; Mustafa D Yoruk; Sukru Tonbak; Yusuf Bolat; Munir Aktas; Ahmet Kalkan; Aykut Ozdarendeli
Journal:  Virol J       Date:  2013-01-03       Impact factor: 4.099

4.  Ribavirin efficacy in an in vivo model of Crimean-Congo hemorrhagic fever virus (CCHF) infection.

Authors:  G H Tignor; C A Hanham
Journal:  Antiviral Res       Date:  1993-12       Impact factor: 5.970

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.